Long Ideas - Shares of MAKO Surgical (NASDAQ:MAKO) are moving up today, trading higher by roughly 5% after yesterday’s earnings report. In the last four months, MAKO tumbled … Continue Reading
Read NowLong Ideas - Incyte (NASDAQ:INCY) shares plummeted today after the company released its second quarter earnings report. Although the report showed top- and bottom-line growth, revenue generation came … Continue Reading
Read NowLong Ideas - ALK inhibitor crizotinib was approved last August under Pfizer’s (NYSE:PFE) marketing name Xalkori for the treatment of some forms of non-small cell lung cancer (NSCLC). … Continue Reading
Read NowLong Ideas - Sources at Roche (OTCQX: RHHBY) told PropThink on Wednesday that products being jointly developed with Halozyme Therapeutics (NASDAQ: HALO) will not face issues seen with … Continue Reading
Read NowLong Ideas - Botox producer Allergan, Inc. (NYSE:AGN) reported its second quarter earnings today, with substantial all-around growth. Net income rose 19% from the last year to $296 … Continue Reading
Read NowLong Ideas - Navidea BioPharma (NASDAQ:NAVB) announced last night that it has entered into a licensing agreement with Alseres Pharmaceuticals (OTC:ALSE) for the development of ALSE’s Altropane imaging … Continue Reading
Read NowLong Ideas - Depomed Inc. (NASDAQ:DEPO) announced last night that it has submitted a New Drug Application to the FDA for Serada, the company’s extended release formulation of … Continue Reading
Read Now